Intra Cellular Therapies | Biaya Penjualan



Cost Of Sales Perubahan Tanggal
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 62.12M 984K 2024-12
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Cytokinetics 463K 79.14M 2024-09
Gilead Sciences USD 1.54B 41M 2025-03
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
J&J USD 7.3B 189M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.31B 73M 2024-12
Prothena 970K 4.78M 2024-09
RedHill Biopharma USD 702K 0 2024-06
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
United Therapeutics USD 277.5M 201.6M 2025-03



Intra Cellular Therapies Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.